InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Explore the detailed record of transactions filed by FOLETTA MARK G, Director. Officer active across 2 companies, notably DEXCOM INC. In total, 12 disclosures have been logged. Total volume traded: €522k. The latest transaction was disclosed on 19 May 2022 — J. Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
01,054 shares0
Common Stock
SEC:0001093557-22-000117:0·
02,139 shares0
Common Stock
SEC:0001209191-22-025451:0·
€20,15241 shares@ €491.50550.0001% mcap30.6% of flow
Common Stock
SEC:0001093557-21-000270·
€20,15241 shares@ €491.50550.0001% mcap15.3% of flow
Common Stock
SEC:0001093557-21-000270:0·
€23,95245 shares@ €532.2720.0001% mcap36.3% of flow
Common Stock
SEC:0001093557-21-000251·
€23,95245 shares@ €532.2720.0001% mcap18.2% of flow
Common Stock
SEC:0001093557-21-000251:0·
€21,84747 shares@ €464.83310.0001% mcap33.1% of flow
Common Stock
SEC:0001093557-21-000235·
€21,84747 shares@ €464.83310.0001% mcap16.6% of flow
Common Stock
SEC:0001093557-21-000235:0·
€195,1442,500 shares@ €78.05750.032% mcap100.0% of flow
Common Stock
SEC:0001209191-21-040544·
€195,1442,500 shares@ €78.05750.032% mcap50.0% of flow
Common Stock
SEC:0001209191-21-040544:0·
0895 shares0
Common Stock
SEC:0001093557-21-000138·
0895 shares0
Common Stock
SEC:0001093557-21-000138:0·
12 of 12 declarations
About FOLETTA MARK G
Mark G. Folette is a Director at Dexcom Inc and AMN Healthcare Services Inc. He plays a key role in corporate governance and strategic decision-making. His expertise is essential for guiding the companies' initiatives.
